Eiko Lifesciences Ltd — Updates, 29-07-2025: Company Update

Eiko LifeSciences' Board has approved a significant increase in its Authorized Share Capital from 14 Cr to 20 Cr, split into 2 Cr equity shares of Rs 10 each. This move, which requires shareholder approval, alters the company's Memorandum of Association. This capital increase provides Eiko LifeSciences with greater flexibility for potential future fundraising initiatives, facilitating growth strategies or other corporate actions by allowing the issuance of additional shares. This is a key step for the company's future financial flexibility.